Protective effects of the fermented milk kefir on x-ray irradiation-induced intestinal damage in B6C3F1 mice

Kiichiro Teruya, Yuki Myojin-Maekawa, Fumio Shimamoto, Hiromitsu Watanabe, Noboru Nakamichi, Koichiro Tokumaru, Sennosuke Tokumaru, Sanetaka Shirahata

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Gastrointestinal damage associated with radiation therapy is currently an inevitable outcome. The protective effect of Kefir was assessed for its usefulness against radiation-induced gastrointestinal damage. A Kefir supernatant was diluted by 2- or 10-fold and administered for 1 week prior to 8 Gray (Gy) X-ray irradiation at a dose rate of 2 Gy/min, with an additional 15 d of administration post-irradiation. The survival rate of control mice with normal drinking water dropped to 70% on days 4 through 9 post-irradiation. On the other hand, 100% of mice in the 10- and 2-fold-diluted Kefir groups survived up to day 9 post-irradiation (p<0.05 and p<0.01, respectively). Examinations for crypt regeneration against 8, 10 and 12 Gy irradiation at a dose rate of 4 Gy/min revealed that the crypt number was significantly increased in the mice administered both diluted Kefir solutions (p<0.01 for each). Histological and immunohistochemical examinations revealed that the diluted Kefir solutions protected the crypts from radiation, and promoted crypt regeneration. In addition, lyophilized Kefir powder was found to significantly recover the testis weights (p<0.05), but had no effects on the body and spleen weights, after 8 Gy irradiation. These findings suggest that Kefir could be a promising candidate as a radiation-protective agent.

Original languageEnglish
Pages (from-to)352-359
Number of pages8
JournalBiological and Pharmaceutical Bulletin
Volume36
Issue number3
DOIs
Publication statusPublished - Mar 1 2013

Fingerprint

Milk
X-Rays
Regeneration
Radiation-Protective Agents
Radiation
Kefir
Drinking Water
Powders
Testis
Radiotherapy
Spleen
Body Weight
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Protective effects of the fermented milk kefir on x-ray irradiation-induced intestinal damage in B6C3F1 mice. / Teruya, Kiichiro; Myojin-Maekawa, Yuki; Shimamoto, Fumio; Watanabe, Hiromitsu; Nakamichi, Noboru; Tokumaru, Koichiro; Tokumaru, Sennosuke; Shirahata, Sanetaka.

In: Biological and Pharmaceutical Bulletin, Vol. 36, No. 3, 01.03.2013, p. 352-359.

Research output: Contribution to journalArticle

Teruya, K, Myojin-Maekawa, Y, Shimamoto, F, Watanabe, H, Nakamichi, N, Tokumaru, K, Tokumaru, S & Shirahata, S 2013, 'Protective effects of the fermented milk kefir on x-ray irradiation-induced intestinal damage in B6C3F1 mice', Biological and Pharmaceutical Bulletin, vol. 36, no. 3, pp. 352-359. https://doi.org/10.1248/bpb.b12-00709
Teruya, Kiichiro ; Myojin-Maekawa, Yuki ; Shimamoto, Fumio ; Watanabe, Hiromitsu ; Nakamichi, Noboru ; Tokumaru, Koichiro ; Tokumaru, Sennosuke ; Shirahata, Sanetaka. / Protective effects of the fermented milk kefir on x-ray irradiation-induced intestinal damage in B6C3F1 mice. In: Biological and Pharmaceutical Bulletin. 2013 ; Vol. 36, No. 3. pp. 352-359.
@article{048e2cd62e4b4190b6efe93224aa2c8a,
title = "Protective effects of the fermented milk kefir on x-ray irradiation-induced intestinal damage in B6C3F1 mice",
abstract = "Gastrointestinal damage associated with radiation therapy is currently an inevitable outcome. The protective effect of Kefir was assessed for its usefulness against radiation-induced gastrointestinal damage. A Kefir supernatant was diluted by 2- or 10-fold and administered for 1 week prior to 8 Gray (Gy) X-ray irradiation at a dose rate of 2 Gy/min, with an additional 15 d of administration post-irradiation. The survival rate of control mice with normal drinking water dropped to 70{\%} on days 4 through 9 post-irradiation. On the other hand, 100{\%} of mice in the 10- and 2-fold-diluted Kefir groups survived up to day 9 post-irradiation (p<0.05 and p<0.01, respectively). Examinations for crypt regeneration against 8, 10 and 12 Gy irradiation at a dose rate of 4 Gy/min revealed that the crypt number was significantly increased in the mice administered both diluted Kefir solutions (p<0.01 for each). Histological and immunohistochemical examinations revealed that the diluted Kefir solutions protected the crypts from radiation, and promoted crypt regeneration. In addition, lyophilized Kefir powder was found to significantly recover the testis weights (p<0.05), but had no effects on the body and spleen weights, after 8 Gy irradiation. These findings suggest that Kefir could be a promising candidate as a radiation-protective agent.",
author = "Kiichiro Teruya and Yuki Myojin-Maekawa and Fumio Shimamoto and Hiromitsu Watanabe and Noboru Nakamichi and Koichiro Tokumaru and Sennosuke Tokumaru and Sanetaka Shirahata",
year = "2013",
month = "3",
day = "1",
doi = "10.1248/bpb.b12-00709",
language = "English",
volume = "36",
pages = "352--359",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "3",

}

TY - JOUR

T1 - Protective effects of the fermented milk kefir on x-ray irradiation-induced intestinal damage in B6C3F1 mice

AU - Teruya, Kiichiro

AU - Myojin-Maekawa, Yuki

AU - Shimamoto, Fumio

AU - Watanabe, Hiromitsu

AU - Nakamichi, Noboru

AU - Tokumaru, Koichiro

AU - Tokumaru, Sennosuke

AU - Shirahata, Sanetaka

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Gastrointestinal damage associated with radiation therapy is currently an inevitable outcome. The protective effect of Kefir was assessed for its usefulness against radiation-induced gastrointestinal damage. A Kefir supernatant was diluted by 2- or 10-fold and administered for 1 week prior to 8 Gray (Gy) X-ray irradiation at a dose rate of 2 Gy/min, with an additional 15 d of administration post-irradiation. The survival rate of control mice with normal drinking water dropped to 70% on days 4 through 9 post-irradiation. On the other hand, 100% of mice in the 10- and 2-fold-diluted Kefir groups survived up to day 9 post-irradiation (p<0.05 and p<0.01, respectively). Examinations for crypt regeneration against 8, 10 and 12 Gy irradiation at a dose rate of 4 Gy/min revealed that the crypt number was significantly increased in the mice administered both diluted Kefir solutions (p<0.01 for each). Histological and immunohistochemical examinations revealed that the diluted Kefir solutions protected the crypts from radiation, and promoted crypt regeneration. In addition, lyophilized Kefir powder was found to significantly recover the testis weights (p<0.05), but had no effects on the body and spleen weights, after 8 Gy irradiation. These findings suggest that Kefir could be a promising candidate as a radiation-protective agent.

AB - Gastrointestinal damage associated with radiation therapy is currently an inevitable outcome. The protective effect of Kefir was assessed for its usefulness against radiation-induced gastrointestinal damage. A Kefir supernatant was diluted by 2- or 10-fold and administered for 1 week prior to 8 Gray (Gy) X-ray irradiation at a dose rate of 2 Gy/min, with an additional 15 d of administration post-irradiation. The survival rate of control mice with normal drinking water dropped to 70% on days 4 through 9 post-irradiation. On the other hand, 100% of mice in the 10- and 2-fold-diluted Kefir groups survived up to day 9 post-irradiation (p<0.05 and p<0.01, respectively). Examinations for crypt regeneration against 8, 10 and 12 Gy irradiation at a dose rate of 4 Gy/min revealed that the crypt number was significantly increased in the mice administered both diluted Kefir solutions (p<0.01 for each). Histological and immunohistochemical examinations revealed that the diluted Kefir solutions protected the crypts from radiation, and promoted crypt regeneration. In addition, lyophilized Kefir powder was found to significantly recover the testis weights (p<0.05), but had no effects on the body and spleen weights, after 8 Gy irradiation. These findings suggest that Kefir could be a promising candidate as a radiation-protective agent.

UR - http://www.scopus.com/inward/record.url?scp=84875537328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875537328&partnerID=8YFLogxK

U2 - 10.1248/bpb.b12-00709

DO - 10.1248/bpb.b12-00709

M3 - Article

VL - 36

SP - 352

EP - 359

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 3

ER -